Evaluation of the use of UPLC-TOFMS with simultaneous [14C]-radioflow detection for drug metabolite profiling:: Application to propranolol metabolites in rat urine

被引:12
作者
Athersuch, T. J. [2 ]
Sison, R. L. [1 ]
Kenyon, A. S. J. [1 ]
Clarkson-Jones, J. A. [1 ]
Wilson, I. D. [1 ]
机构
[1] AstraZeneca, Dept Clin Pharmacol Drug Metab & Pharmacokinet, Mereside, Macclesfield SK10 4TG, Cheshire, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Biomol Med, Div Surg Oncol Reprod Biol & Anaesthet SORA, Fac Med, London SW7 2AZ, England
基金
英国生物技术与生命科学研究理事会;
关键词
propranolol; UPLC-TOFMS; radiochemical detection; metabolism; in vivo;
D O I
10.1016/j.jpba.2008.05.003
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The non-selective beta-adrenergic receptor antagonist propranolol [1-(isopropylamino)-3-(1-naphthoxy)-2-propanol] is metabolised extensively in vivo. Enumerating and identifying the many metabolites that result from multiple biotransformations provides a considerable analytical challenge, greatly aided by efficient chromatography coupled to sensitive mass spectrometric detection. Here the use of the newly introduced high-resolution technique of "ultra performance liquid chromatography" (UPLC) linked to quadrupole time-of-flight mass spectrometry (TOFMS) with simultaneous [C-14]-radioflow detection was applied to rapid metabolite profiling. [C-14]-propranolol, dosed intraperitoneally to rat at 25 mg kg(-1) and 200 mu Ci kg(-1) was used as a model compound for this evaluation. Some 14 metabolites were detected in the urine by this technique including a number of conjugated metabolites such as sulphates, several isobaric glucuronides and two novel di-glucuronides. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 157
页数:7
相关论文
共 35 条
[31]  
WALLE T, 1972, J PHARMACOL EXP THER, V182, P83
[32]   High resolution "Ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies [J].
Wilson, ID ;
Nicholson, JK ;
Castro-Perez, J ;
Granger, JH ;
Johnson, KA ;
Smith, BW ;
Plumb, RS .
JOURNAL OF PROTEOME RESEARCH, 2005, 4 (02) :591-598
[33]   PLASMA-CONCENTRATIONS OF PROPRANOLOL AND 4-HYDROXYPROPRANOLOL DURING CHRONIC ORAL PROPRANOLOL THERAPY [J].
WONG, L ;
NATION, RL ;
CHIOU, WL ;
MEHTA, PK .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (02) :163-167
[34]   Side-chain metabolism of propranolol:: involvement of monoamine oxidase and aldehyde reductase in the metabolism of N-desisopropylpropranolol to propranolol glycol in rat liver [J].
Wu, XZ ;
Noda, A ;
Noda, H ;
Imamura, Y .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2001, 129 (04) :361-368
[35]   Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS) [J].
Yin, Peiyuan ;
Zhao, Xinjie ;
Li, Qiurong ;
Wang, Jiangshan ;
Li, Jieshou ;
Xu, Guowang .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (09) :2135-2143